Advice You - Business

Strategic Planning entails the making of schemes to be adhered to by an entire organ

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ization. This pertains to the entire organization’s achievement and progress over a

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ertain period of time in the future. It also takes into account the way industry con

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

itions change with the times - in areas such as technology and communications.

The

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

particular nature of the organization, as brought out by its leadership, its culture

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

complexities in its environment, its size and other specific aspects prevalent ther

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

, determine its Strategic Planning mode. Thus, there arise a number of models, appro

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

aches and perspectives of Strategic Planning. These may be based on goals or issues

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

r other criteria.

An organization’s planners may well know the components of a Stra

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

egic Plan. Still, in order to clarify and elucidate the organization’s plans and ver

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

fy that the individual plans of the key persons concerned comply with the common pla

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

n, the Strategic Planning process is well worth considering. Strategic Planning serv

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

s many purposes:

•It helps cultivate a feeling of ownership of the plan among the p

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

rticipants in planning.

•It helps bring focus on the key priorities of the organiza

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

tion, and thereby ensures the most optimum effective use of the organization’s avail

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ble resources.

•It sets and establishes realistic and achievable goals for a period

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

of time in keeping with the organization’s capacity.

•It forwards such goals and ob

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

jectives defined to every constituent of the organization. Following these, progress

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

can be measured from time to time.

•It redefines the organization’s purpose.

•It e

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

tablishes a mechanism for informing about changes in goals and objectives, when made

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/44897/adviceyou-Strategic-Planning.html">Strategic Planning</a>

BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/44897/adviceyou-Strategic-Planning.html]Strategic Planning[/url]

Strategy making process for business existing in a particular industry involves the study of many factors in the industry.

It is happening to people all over the country; in large cities and small towns. Companies are downsizing or closing. You may be with the same firm for 20+ years in a senior position and still you are not immune to the chopping block.

Most of the disappointment, anger, and frustration people feel is when they do or say something and expect something specific to happen. When that thing doesn’t happen, their desire for control kicks in and they get all out of whack. When that response doesn’t come, just be prepared to let go, flow, and react to it the best you can.

Tags

Links

Advice You - Strategic Planning

Related Articles: